Triglycerides to apolipoprotein A1 ratio: an effective insulin resistance-associated index in identifying metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
2024

Using Triglycerides to Apolipoprotein A1 Ratio to Identify Fatty Liver Disease in Diabetes

Sample size: 779 publication Evidence: high

Author Information

Author(s): Wang Wei, Chen Yang, Tu Mei, Chen Hang Ju

Primary Institution: National Metabolic Management Center, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China

Hypothesis

This study aims to evaluate the correlation between TG/APOA1 and MAFLD, as well as compare the efficacy of TG/APOA1 with other insulin resistance indexes in identifying MAFLD among individuals with T2DM.

Conclusion

TG/APOA1 serves as an effective index of insulin resistance in identifying MAFLD, offering advantages in the screening of MAFLD in T2DM.

Supporting Evidence

  • TG/APOA1 was significantly higher in the MAFLD group compared to non-MAFLD.
  • TG/APOA1 showed significant associations with liver fibrosis scores.
  • TG/APOA1 outperformed TG/HDL-c and TyG index in identifying MAFLD.

Takeaway

This study found that a specific ratio of triglycerides to a protein called apolipoprotein A1 can help doctors find liver problems in people with diabetes.

Methodology

This cross-sectional study recruited individuals with T2DM and used abdominal CT scans to measure liver fat, comparing TG/APOA1 with other insulin resistance indexes.

Limitations

The study used CT scans instead of liver biopsies for diagnosis and was cross-sectional, limiting the ability to establish causation.

Participant Demographics

The mean age of participants was 53.5 years, with 52.8% being men.

Statistical Information

P-Value

P<0.001

Confidence Interval

95% CI: 1.840-2.380

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fendo.2024.1384059

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication